GPCR FY 2023 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$103M

Net Income

-$90M

EPS (Diluted)

$-2.43

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$82M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$482M

Total Liabilities

$29M

Stockholders' Equity

$453M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$103M	-$53M	-95.5%
Net Income	-$90M	-$51M	-74.6%